Sfoglia per Rivista
Oral chemotherapy: an innovative choice
2015-01-01 Bergui, L.; Scaldaferri, M.; Sciorsci, E.; Valinotti, G.; Ghiggia, A.; Cavallo, F.; Ferrero, S.; Ghione, P.; Castelli, L.; Torta, R.
Oral melphalan at diagnosis hampers adeguate collection of peripheral blood progenitor cells in multiple myeloma.
2002-01-01 Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P; Pileri A
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors.
2013-01-01 Russo Rossi A;Breccia M;Abruzzese E;Castagnetti F;Luciano L;Gozzini A;Annunziata M;Martino B;Stagno F;Cavazzini F;Tiribelli M;Visani G;Pregno P;Musto P;Fava C;Sgherza N;Albano F;Rosti G;Alimena G;Specchia G
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group
2007-01-01 Locatelli, Franco; Zecca, Marco; Pession, Andrea; Morreale, Giuseppe; Longoni, Daniela; Di Bartolomeo, Paolo; Porta, Fulvio; Fagioli, Franca; Nobili, Bruno; Bernardo, Maria Ester; Messina, Chiara
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
2020-01-01 Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M.
Outcome of patients with chronic phase CML treated with dasatinib or nilotinib after failure of second prior TKIs.
2011-01-01 A. Russo Rossi; F. Castagnetti; M. Breccia; L. Luciano; A. Gozzini; M. Annunziata; B. Martino; F. Stagno; F. Cavazzini; M. Tiribelli; G. Visani; P. Pregno; P. Musto; C. Fava; P. Avanzini; D. Turri; F. Porretto; E. Abruzzese; N. Sgherza; F. Albano; G. Specchia.
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation
2018-01-01 Salvatore D.; Labopin M.; Ruggeri A.; Battipaglia G.; Ghavamzadeh A.; Ciceri F.; Blaise D.; Arcese W.; Socie G.; Bourhis J.H.; Van Lint M.T.; Bruno B.; Huynh A.; Santarone S.; Deconinck E.; Mohty M.; Nagler A.
Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative myeloproliferative disorders
2005-01-01 Morotti A; Arruga F; Messa F; Defilippi I; Pautasso M; Baraban D; Giugliano E; Scaravaglio P; Rege-Cambrin G; Taulli R; Gottardi E; Cilloni D; Saglio G
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
2012-01-01 Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia.
2013-01-01 Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S.
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
2002-01-01 F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.
1996-01-01 AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S
Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia
2001-01-01 Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A
Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience
2015-01-01 Dreyling, Martin; Ferrero, Simone
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS
2014-01-01 Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G
PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS
2017-01-01 Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major
2006-01-01 GALANELLO R; PIGA A; FORNI GL; BERTRAND Y; FOSCHINI ML; BORDONE E ;LEONI G; LAVAGETTO A; ZAPPU A; LONGO F; MASERUKA H; HEWSON N; SECHAUD R; BELLELI R; ALBERTI D
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients
2015-01-01 Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco
Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor mass
1991-01-01 BIANCHI A; OMEDÈ P; ATTISANO C; CAMPONI A; DIANZANI U; BOCCADORO M; PILERI A; MASSAIA M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Oral chemotherapy: an innovative choice | 2015 | Bergui, L.; Scaldaferri, M.; Sciorsci, E.; Valinotti, G.; Ghiggia, A.; Cavallo, F.; Ferrero, S.; Ghione, P.; Castelli, L.; Torta, R. | |
Oral melphalan at diagnosis hampers adeguate collection of peripheral blood progenitor cells in multiple myeloma. | 2002 | Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P; Pileri A | |
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors. | 2013 | Russo Rossi A;Breccia M;Abruzzese E;Castagnetti F;Luciano L;Gozzini A;Annunziata M;Martino B;Stagno F;Cavazzini F;Tiribelli M;Visani G;Pregno P;Musto P;Fava C;Sgherza N;Albano F;Rosti G;Alimena G;Specchia G | |
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group | 2007 | Locatelli, Franco; Zecca, Marco; Pession, Andrea; Morreale, Giuseppe; Longoni, Daniela; Di Bartolomeo, Paolo; Porta, Fulvio; Fagioli, Franca; Nobili, Bruno; Bernardo, Maria Ester; Messina, Chiara | |
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs | 2020 | Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M. | |
Outcome of patients with chronic phase CML treated with dasatinib or nilotinib after failure of second prior TKIs. | 2011 | A. Russo Rossi; F. Castagnetti; M. Breccia; L. Luciano; A. Gozzini; M. Annunziata; B. Martino; F. Stagno; F. Cavazzini; M. Tiribelli; G. Visani; P. Pregno; P. Musto; C. Fava; P. Avanzini; D. Turri; F. Porretto; E. Abruzzese; N. Sgherza; F. Albano; G. Specchia. | |
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation | 2018 | Salvatore D.; Labopin M.; Ruggeri A.; Battipaglia G.; Ghavamzadeh A.; Ciceri F.; Blaise D.; Arcese W.; Socie G.; Bourhis J.H.; Van Lint M.T.; Bruno B.; Huynh A.; Santarone S.; Deconinck E.; Mohty M.; Nagler A. | |
Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative myeloproliferative disorders | 2005 | Morotti A; Arruga F; Messa F; Defilippi I; Pautasso M; Baraban D; Giugliano E; Scaravaglio P; Rege-Cambrin G; Taulli R; Gottardi E; Cilloni D; Saglio G | |
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2012 | Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S | |
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. | 2013 | Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S. | |
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. | 2002 | F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI | |
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications. | 1996 | AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S | |
Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia | 2001 | Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A | |
Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience | 2015 | Dreyling, Martin; Ferrero, Simone | |
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS | 2014 | Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G | |
PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS | 2017 | Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR | |
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major | 2006 | GALANELLO R; PIGA A; FORNI GL; BERTRAND Y; FOSCHINI ML; BORDONE E ;LEONI G; LAVAGETTO A; ZAPPU A; LONGO F; MASERUKA H; HEWSON N; SECHAUD R; BELLELI R; ALBERTI D | |
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A | |
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients | 2015 | Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco | |
Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor mass | 1991 | BIANCHI A; OMEDÈ P; ATTISANO C; CAMPONI A; DIANZANI U; BOCCADORO M; PILERI A; MASSAIA M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile